Pet Drug Reports

Tulathromycin (Draxxin, Macrosyn): adverse event reports that FDA received

Active ingredient

Also sold as: Draxxin, Macrosyn, Increxxa, Tulissin, Tulaven, Arovyn, and 3 more brand names.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Read this first. FDA says this about the data:

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .

This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.

Contacting a veterinarianHow to report to FDA

From January 2005 to June 2026, FDA received 3,191 adverse event reports that name a drug with tulathromycin as its active ingredient. Of the 3,191 reports, 2,292 (71.8%) are about cattle. 344 reports are about people who were exposed to the drug (10.8%).

In January to March 2026, FDA received 25 reports that name this drug. The signs that appear in the largest number of the 3,191 reports are "Death" and "Lack of efficacy (bacteria) - NOS". A report is not proof that a drug caused a sign.

Reports that name this drug fell by 5.1% in the 12 months to June 2026, compared with the 12 months before. Reports for all animal drugs fell by 4.6% in the same periods. The newest months can get more reports in a later update. Reports about cattle are 71.8% of the reports that name this drug, and 2.3% of all reports.

Since the last update of the FDA data

The latest update of the FDA data, recorded on , changed no count of this page.

January to March 2026 is the latest closed quarter in the data. In that quarter FDA received 25 reports that name tulathromycin: 2 dog, 1 cat, 0 horse, 22 other or not given.

All updatesFeed of updates (RSS)

Signs that the reports list

A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 3,191 reports that list the sign. One report can list more than one sign.

The sign that is in the largest number of the reports comes first.

  1. Death36.2%1,156 reports
  2. Lack of efficacy (bacteria) - NOS[the product did not have the expected effect: target not specified]30.3%968 reports
  3. Lack of efficacy - NOS[the product did not have the expected effect]26.2%835 reports
  4. Injection site pain[pain where the injection was given]5.4%172 reports
  5. Accidental exposure[exposure that was not intended]5.2%165 reports
  6. Necropsy performed4.7%150 reports
  7. Unclassifiable adverse event[event that fits no dictionary term]4.3%137 reports
  8. Injection site swelling[swelling where the injection was given]3.6%114 reports
  9. PR-lung(s), lesion(s)[legacy FDA term: lesions found in the lungs]3.1%99 reports
  10. Injection site reaction NOS[reaction nos where the injection was given]3%95 reports
  11. Death by euthanasia[the animal was euthanized]2.7%87 reports
  12. No sign[no clinical sign was reported]2.7%85 reports
Show the next 16 signs
  1. Containers, Abnormal[a product quality report, not a sign in an animal]2.6%82 reports
  2. Unrelated death1.9%61 reports
  3. Color, Abnormal[a product quality report, not a sign in an animal]1.8%59 reports
  4. Containers, Damaged[a product quality report, not a sign in an animal]1.7%55 reports
  5. Other abnormal test result NOS[abnormal laboratory result, type not specified]1.7%55 reports
  6. Anaphylaxis[sudden severe allergic-type reaction]1.6%51 reports
  7. Unexplained death1.4%46 reports
  8. Vials, Damaged[a product quality report, not a sign in an animal]1.4%45 reports
  9. NT - Abnormal necropsy finding NOS[NOS: not otherwise specified]1.4%44 reports
  10. Abnormal test result1.3%42 reports
  11. Puncture wound1.3%42 reports
  12. Lack of efficacy (mycoplasma) - NOS[the product did not have the expected effect: target not specified]1.3%41 reports
  13. Recumbency[lying down and unable or unwilling to rise]1.3%41 reports
  14. Injection site inflammation[inflammation where the injection was given]1.3%40 reports
  15. Pneumonia[lung infection or inflammation]1.2%37 reports

The list shows 30 of 646 coded signs. A report is not proof that a drug caused a sign. Download all signs (CSV)

Reports by species

The share is of all 3,191 reports that name tulathromycin. The other reports give a different species or no species.

Reports for each month, Jul 2021 to Jun 2026

Dog5 reports

No chart: no month has 5 or more reports.

Cat4 reports

No chart: no month has 5 or more reports.

Horse1 report

No chart: no month has 5 or more reports.

Other or not given753 reports. Largest count in one month: 28 (Nov 2023)

The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

Reports by year

  • Dog
  • Cat
  • Horse
  • Other or not given
Reports that name tulathromycin, by the year in which FDA received them and by species
YearDogCatHorseOther or not givenAll species
20262104346
2025000168168
2024120164167
2023001196197
2022210110113
2021001127128
2020110113115
2019000181181
2018020117119
2017100122123
2016000136136
2015120119122
2014110179181
2013000161161
2012011187189
2011010189190
2010102169172
2009212129134
2008200142144
2007200174176
2006100152153
20050007676

2026 has the reports that FDA received through Jun 2026. Download the years (CSV)

What the reports record

Outcome at the time of the report

  • Recovered/Normal7.8%249
  • Recovered with Sequela[recovered, with a lasting effect]1.3%42
  • Ongoing8.1%258
  • Died54.2%1,730
  • Euthanized2.5%79
  • Outcome Unknown35.5%1,132

An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 3,191 reports that name tulathromycin.

A report about more than one animal can have more than one outcome.

Kind of report

  • Safety issue44.9%1,434
  • Lack of expected effectiveness40%1,277
  • Both safety and lack of expected effectiveness2.6%84
  • Manufacturing or product defect12.3%391
  • Other0.2%5

1,971 reports say if the event was serious. 84.4% of them have the serious flag. The person who sends the report sets the flag.

Show age, weight, breed and route

Age of the animal

  • Under 1 year30.7%979
  • 1 to 3 years3.1%99
  • 4 to 7 years1%33
  • 8 to 11 years0.4%14
  • 12 years and over9.1%289
  • Age not given55.7%1,777

Weight of the animal

  • Under 5 kg (11 lb)0.8%24
  • 5 to 9.9 kg (11 to 22 lb)0.6%18
  • 10 to 24.9 kg (22 to 55 lb)0.6%19
  • 25 to 44.9 kg (55 to 99 lb)1.6%50
  • 45 kg and over (99 lb and over)54%1,724
  • Weight not given42.5%1,356

Breed, where the report gives one breed

A breed with many animals has many reports.

Route in the report

  • Subcutaneous67.7%2,159
  • Intramuscular4.5%145
  • Topical0.8%25
  • Parenteral0.6%18
  • Oral0.5%16
  • Other0.4%13

Each bar is on a scale of 0 to 100%.

Approved animal drugs with this active ingredient (FDA Green Book)

This section is reference data. It has no report count.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Brand names

  • Draxxin
  • Macrosyn
  • Increxxa
  • Tulissin
  • Tulaven
  • Arovyn
  • Tulieve
  • RESPIRmycin
  • Tulaject

What the Green Book records give

Applications with an approval in force
17
Approved species
Cattle, Swine
Dose forms
Injectable Solution, Liquid (Solution)
Routes
Intramuscular, Subcutaneous
Sale
RX (prescription)
Earliest approval date in the records

The species, dose forms and routes are the words of the Green Book records for all the applications together. One product can have fewer. The label of a product gives its approved use.

Applications in the Green Book of 2 Nov 2026, pioneer applications (NADA) first
Brand nameActive ingredientsSponsorApproved speciesApplication
DraxxinTulathromycinZoetis Inc.Cattle, SwineNADA 141-244
Draxxin 25 Injectable SolutionTulathromycinZoetis Inc.Cattle, SwineNADA 141-349
MacrosynTulathromycinBimeda Animal Health Ltd.Cattle, SwineANADA 200-657
Increxxa 25TulathromycinElanco US Inc.Cattle, SwineANADA 200-665
IncrexxaTulathromycinElanco US Inc.Cattle, SwineANADA 200-666
Tulissin 25TulathromycinVirbac AH, Inc.Cattle, SwineANADA 200-668
Tulissin 100TulathromycinVirbac AH, Inc.Cattle, SwineANADA 200-669
Tulaven 100TulathromycinCeva Sante AnimaleCattle, SwineANADA 200-711
Tulaven 25TulathromycinCeva Sante AnimaleCattle, SwineANADA 200-712
ArovynTulathromycinIntervet, Inc.Cattle, SwineANADA 200-715
TulieveTulathromycinNorbrook Laboratories, Ltd.Cattle, SwineANADA 200-723
RESPIRmycinTulathromycinParnell Technologies Pty. Ltd.Cattle, SwineANADA 200-730
Tulathromycin InjectionTulathromycinHikma Pharmaceuticals USA, Inc.Cattle, SwineANADA 200-742
RESPIRmycin 25TulathromycinParnell Technologies Pty. Ltd.Cattle, SwineANADA 200-745
Tulaject 100TulathromycinCronus Pharma Specialities India Private Ltd.Cattle, SwineANADA 200-773
TulajectTulathromycinCronus Pharma Specialities India Private Ltd.Cattle, SwineANADA 200-774
Macrosyn 25TulathromycinBimeda Animal Health Ltd.Cattle, SwineANADA 200-844

Other pages with this ingredient

A report names a drug by its set of active ingredients. Each set has its own page. The list is in order of name.

Next in the A to Z list

All drugs by active ingredient. Brand names A to Z

FDA pages for this drug

The site checked these addresses on . The links open in a new tab.

Cite this page

Pet Drug Reports. Tulathromycin: adverse event reports that FDA received. https://petdrugreports.com/drug/tulathromycin/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .

Embed this card on your site

Copy this code into your page. The card shows the figures above with their source. A line under the card links to this page.

How embedding works. It is free. Keep the link in the card and the link line under it.

Where the data come from

The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. The site does not use the application number that a record has.

The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.

Questions about these reports

Which brand are these reports about?

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book section of this page lists the brand names with this active ingredient.

Do the reports show that the drug caused the signs?

No. FDA states this about the data.

When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.

The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices

How many reports did FDA receive in the latest 12 months?

FDA received 149 reports in the 12 months to June 2026. It received 157 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

What kinds of report are in the count?

Of the 3,191 reports received from January 2005 to June 2026, 44.9% are about a safety issue only. 42.7% are about a lack of expected effectiveness, alone or with a safety issue. 12.3% are about a defect of the product or its package.